TPG Capital has bought a majority stake in Cancer Treatment Services International (CTSI), a US cancer treatment chain focused on India and South Asia. AVCJ understands that the firm paid $33 million for a 65% interest.
Following its $50 million Series C round, investors in Hua Medicine are waiting for the company to fulfill its potential as a poster child of innovation in China
Harvest Fund Management has led a $50 million Series C round – which was more than 3x oversubscribed – for China-based clinical-stage diabetes treatment developer Hua Medicine.
China-focused GP Qiming Venture Partners is planning to raise a healthcare-dedicated fund in the US that will help China- and US-based start-ups expand in both markets.
Maverick Capital Ventures, the VC affiliate of hedge fund Maverick Capital, has led a INR1 billion ($15 million) Series B round for Indian online pharmaceutical platform 1mg.
San Diego-based cancer treatment developer Sorrento Therapeutics has raised about $150 million from a group of investors led by China-focused healthcare specialist Ally Bridge Group.
Samara Capital has paid INR1.51 billion ($22.7 million) for the Indian division of South African drug maker Adcock Ingram Holdings.
Healthcare-focused GP Ally Bridge Group has led a Series B round of funding for LinkDoc Technology, an oncology-focused big data company based in China.
TVM Capital Healthcare Partners, which focuses on healthcare investments in emerging markets, has deepened its coverage of Southeast Asia with the appointment of one operating partner and two senior advisors in Singapore.
CITIC Private Equity (CITIC PE) has invested an undisclosed sum in New Journey Hospital Group, a Chinese cancer hospital operator.
Carlyle Group-backed hospital operator Zhongmei Healthcare has filed for a Hong Kong IPO.
Goldman Sachs has committed $37 million to cardiac valve developer Venus Medtech.
Affinity Equity Partners has bought Australia-based clinic management software developer Medical Director for A$155 million ($117 million).
J-Star has completed its takeover of Japanese drugstore chain Aisei Pharmacy in a deal valued at JPY11.4 billion ($101 million).
Singapore-based venture capital firm DMP has led a $2.5 million Series A round for clinical services marketplace Medical Departures.
Hospitals have emerged as a phenomenally popular target for private equity in China, but it may take time for ambitious growth projections to be realized
Fosun Kinzon Capital, a VC arm backed by Fosun Group, has led a RMB100 million ($15 million) Series B round for Easyhin, a Chinese mobile app that provides healthcare services to mothers and children.
Bain Capital has acquired a majority stake in China-based hospital operator Asia Pacific Medical Group (APMG) for $150 million. With many investors pursuing hospital roll-up strategies – and pushing up M&A valuations – it will focus on expanding the...
The International Finance Corporation (IFC), Sabre Partners and other anchor investors have committed INR2.92 billion ($43.6 million) to Indian cancer care services provider HeathCare Global Enterprises as part of its IPO.
Ping An Ventures, the VC arm of China's Ping An Insurance Group, has led a $10 million Series A round for Hong Kong-based genetic test developer Prenetics.
US-based GP Frazier Healthcare Partners is leading a $41 million Series A round for Japanese medical research and development company Takeda Pharmaceutical.
Technological progress and changing consumer habits are bringing long-overdue change to India’s overworked healthcare system. Taking advantage will mean mastering the unique challenges of the market
Malaysian health and wellness company PurelyB has acquired Singaporean yoga lifestyle website Stretch City.
Warburg Pincus has generated $425.7 million by selling an approximately 16% interest in US-listed biopharmaceuticals developer China Biologic Products.